CSIMarket
 


Biodelivery Sciences International Inc   (BDSI)
Other Ticker:  
 

Cumulative Biodelivery Sciences International Inc 's Leverage Ratio for Trailing Twelve Months Period

BDSI's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

BDSI Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
Y / Y Equity Growth 73.53 % 28.04 % 34.38 % 42.13 % 55.14 %
Y / Y Total Liabilities Growth 3.88 % 0.93 % 0.82 % 11.04 % 16.37 %
Leverage Ratio for Trailing Twelve Months Period 1.01 1.18 1.25 1.34 1.42
Total Ranking # 2256 # 2088 # 2134 # 2290 # 2279
Seq. Equity Growth 52.98 % 7.77 % 4.65 % 0.57 % 12.88 %
Seq. Total Liabilities Growth 2.61 % -2.28 % 2.35 % 1.23 % -0.31 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2021
On the trailing twelve months basis Despite net new borrowings of 2.61% Biodelivery Sciences International Inc managed to decrease Leverage Ratio for Trailing Twelve Months Period in IV. Quarter to 1.01, below Biodelivery Sciences International Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 380 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Biodelivery Sciences International Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are BDSI's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 381
Sector # 711
S&P 500 # 1771


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
76.53 4.96 0.69
(Dec 31 2016)   (Dec. 30, 2014)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2021, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Vera Therapeutics Inc   2.68 
Phibro Animal Health Corporation  2.65 
Akebia Therapeutics Inc   2.56 
Infinity Pharmaceuticals Inc   2.54 
Rigel Pharmaceuticals Inc  2.54 
Assertio Holdings inc   2.48 
Rockwell Medical inc   2.44 
Mei Pharma Inc   2.43 
Ionis Pharmaceuticals Inc  2.42 
Scynexis Inc   2.39 
Collegium Pharmaceutical Inc   2.32 
Zoetis Inc   2.22 
Carisma Therapeutics Inc   2.20 
2seventy Bio Inc   2.16 
Obseva Sa  2.15 
Pieris Pharmaceuticals Inc   2.13 
Iterum Therapeutics Plc  2.10 
Vaccinex Inc   2.07 
Revance Therapeutics Inc   2.04 
Bristol myers Squibb Company  2.03 
Athenex Inc   2.02 
Merck and Co Inc   1.96 
Harmony Biosciences Holdings inc   1.92 
China Pharma Holdings Inc   1.92 
Nanobiotix S a   1.91 
Insmed Inc  1.90 
Ironwood Pharmaceuticals inc   1.89 
Amicus Therapeutics inc   1.86 
Adc Therapeutics Sa  1.84 
Scopus Biopharma Inc   1.81 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com